Breast cancer biomarkers before and after neoadjuvant chemotherapy: does repeat testing impact therapeutic management?

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

Antonio C. Wolff, M. Elizabeth H. Hammond, Jared N. Schwartz et al. · Journal of Clinical Oncology · 2006 · 4.5K citations · Full text

Medicine, Oncology, Pathology +11

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

Antonio C. Wolff, M. Elizabeth Hammond, David G. Hicks et al. · Journal of Clinical Oncology · 2013 · 4.1K citations · Full text

Medicine, Oncology, Pathology +14

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

Antonio C. Wolff, M. Elizabeth H. Hammond, Jared N. Schwartz et al. · Archives of Pathology & Laboratory Medicine · 2007 · 1.9K citations

Medicine, Oncology, Pathology +11

Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome

Ian F. Faneyte, Jolanda Schrama, J.L. Peterse et al. · British Journal of Cancer · 2003 · 316 citations · Full text

Medicine, Oncology, Pharmacology +15

Preoperative Therapy With Trastuzumab and Paclitaxel Followed by Sequential Adjuvant Doxorubicin/Cyclophosphamide for HER2 Overexpressing Stage II or III Breast Cancer: A Pilot Study

Harold J. Burstein, Lyndsay N. Harris, Rebecca Gelman et al. · Journal of Clinical Oncology · 2002 · 277 citations

Medicine, Oncology, Pharmacology +17